Special Article | Open Access
Carla S Coffin, Scott K Fung, Mang M Ma, "Management of Chronic Hepatitis B: Canadian Association for the Study of the Liver Consensus Guidelines", Canadian Journal of Gastroenterology and Hepatology, vol. 26, Article ID 506819, 2 pages, 2012. https://doi.org/10.1155/2012/506819
Management of Chronic Hepatitis B: Canadian Association for the Study of the Liver Consensus Guidelines
Chronic hepatitis B (CHB) is a dynamic disease that is influenced by host and virological factors. The management of CHB has become more complex with the increasing use of long-term oral nucleos/tide analogue antiviral therapies and the availability of novel diagnostic assays. Furthermore, there is often a lack of robust data to guide optimal management such as the selection of therapy, duration of treatment, potential antiviral side effects and the treatment of special populations. In November 2011, the Canadian Liver Foundation and the Canadian Association for the Study of the Liver convened a consensus conference to review the literature and analyze published data, including other international expert guidelines on CHB management. The proceedings of the consensus conference are summarized and provide updated clinical practice guidelines to assist Canadian health care providers in the prevention, diagnosis, assessment and treatment of CHB.
Copyright © 2012 Canadian Association for the Study of the Liver. This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes.